Los Angeles hospital covid-19 testing patient Los Angeles

FDA authorizes emergency use of Eli Lilly monoclonal antibody therapy to treat COVID-19

Reading now: 108
www.fox29.com

FILE - In this photo illustration, the Eli Lilly and Company logo is seen displayed on a smartphone. LOS ANGELES - The U.S.

Food and Drug Administration issued an emergency use authorization for Eli Lilly and Company’s monoclonal antibody therapy bamlanivimab to treat mild-to-moderate cases of COVID-19, according to a news release.“Monoclonal antibodies are used to treat many diseases, including some types of cancer.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA